摘要
目的 :探讨绝经后妇女骨质疏松的治疗方法。方法 :将 86例绝经后骨质疏松患者随机分成 A组 (实验组 ,口服利维爱加钙尔奇 - D片 )、B组 (对照组 ,单服钙尔奇 - D片 ) ,比较两组的更年期症状与骨密度 (BMD)、血清降钙素 (h-CT)、血清骨钙素 (BGP)和甲状旁腺素 (PTH)等指标的变化情况。结果 :A组的临床有效率为 79.0 7% ,明显高于对照组(5 8.14 % ,P<0 .0 5 )。A组 BMD明显增加 (P<0 .0 5 ) ,BGP、h- CT水平显著增高 (P<0 .0 1) ,PTH水平显著降低 (P<0 .0 5 )结论 :口服利维爱加钙尔奇 - D片 。
Objectives:To view the curative effect of estrogen replacement therapy(ERT) in postmenopausal osteoporosis.Methods: 86 cases of postmenopausal osteoporosis were divided into experimental group(given oral Livial and Caltrated D)and control group(given oral Caltrated D).The clinically effective rates and bone metabolite indexes including bone mass density(BMD),bone glaconfaining protein(BGP),calcitonin(CT)and parathormone(PTH)were measured.Results: The clinically effective rate in experimental group was 79.07%,its significantly higher than that in control group(58.14%, P < 0.05 ).The levels of BMD,BGP,CT were increased significantly( P <0.05, P <0.01),and PTH was decreased significantly( P <0.05)in erperimental group than that in control group. Conclusions: It was suggested that ERT was one of an effectively therapeutic method for postmenopausal osteoporosis.
出处
《实用妇产科杂志》
CAS
CSCD
北大核心
2002年第5期299-300,共2页
Journal of Practical Obstetrics and Gynecology
关键词
绝经
雌激素补充疗法
骨质疏松症
骨密度
骨代谢
Osteoporosis
Estrogen replacement therapy
Bone mass density
Bone metabolite
Menopause
